Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

2 clinical trials · Condition

Record	Firm	Date
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma (NCT07583810)	City of Hope Medical Center	2026-12-16
Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma (NCT03680586)	M.D. Anderson Cancer Center	2019-02-04

Every clearance here is in the API, with alerts when new ones post.